John Gary Montana

This inventor holds 68 USPTO granted patents and 7 published patent applications, plus 10 CIPO patents and 16 EPO patents, primarily in NIK Inhibitors (CPC class 5442). Top assignees: Darwin Discovery Limited, Chiroscience, Ltd., Janssen Pharmaceutica Nv. Active years: 1997-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Gary Montana. Retrieved from https://idiyas.com/inventor/john-gary-montana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 68 (Patent Applications = 7)

% Patents Active = 72.1

CIPO Patents = 10 (Patent Applications = 8)

EPO Patents = 16 (Patent Applications = 12)

Average Co-Inventor Count = 3.5

ph-index = 12

Forward Citations = 579(Granted Patents)

Forward Citations (Not Self Cited) = 558(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cambridge, GB (1997 - 2004)
Harlow, GB (2010 - 2017)
Essex, GB (2010 - 2020)
Ashdon, GB (2020)

Company Filing History:

39 out of 90

Darwin Discovery Limited

Janssen Pharmaceutica Nv

patents

4. 4 out of 4

Pulmagen Therapeutics (Asthma) Limited

8. 1 out of 834,453

Other

patents

Years Active: 1997-2020

Loading Chart...

Areas of Expertise:

NIK Inhibitors

Heterocyclic Compounds

Hydroxamic Acid Derivatives

Quinoline Derivatives

Pyrazolopyrimidine

Peptidyl Compounds

Indoles

Adenine Inhibitors

Bicyclic Aryl Carboxamides

Thienopyrimidine

Sulphone Compounds

Xanthines

68 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10822342 - Pyrazolopyrimidine derivatives as NIK inhibitors (2020-11-03),

2. 10626089 - Quinoline derivative in crystal form (2020-04-21),

3. 10323045 - Thienopyrimidine derivatives as NIK inhibitors (2019-06-18),

4. 10221180 - Pyrazolopyrimidine derivatives as NIK inhibitors (2019-03-05),

5. 10005776 - Compounds as NIK inhibitors (2018-06-26),

6. 10005773 - [object Object] (2018-06-26),

7. 9981963 - [object Object] (2018-05-29),

8. 9981962 - Pyrazole derivatives as NIK inhibitors (2018-05-29),

9. 9643964 - 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer (2017-05-09),

10. 9067905 - Sulphone compounds and methods of making and using same (2015-06-30),

11. 8669248 - Adenine inhibitors of HSP90 (2014-03-11),

12. 8394836 - Indoles and their therapeutic use (2013-03-12),

13. 8394830 - Quinolines and their therapeutic use (2013-03-12),

14. 8173812 - Quinolines and their therapeutic use (2012-05-08),

15. 7893085 - Aza-benzothiophenyl compounds and methods of use (2011-02-22),

Title: The Innovative Mind of John Gary Montana

Introduction: John Gary Montana, a brilliant inventor based in Cambridge, GB, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: John Gary Montana holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, John Gary Montana has worked with leading tech companies and research institutions, spearheading projects that have revolutionized various industries. His keen eye for detail and passion for problem-solving have led to the development of cutting-edge solutions.

Collaborations: Throughout his career, John Gary Montana has collaborated with top scientists, engineers, and designers from around the world, fostering a culture of innovation and excellence. His ability to work in multidisciplinary teams has resulted in the successful implementation of complex projects.

Conclusion: John Gary Montana's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the field of inventions. His work continues to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.